The US Biomedical Advanced Research and Development Authority awarded biotech firm Moderna with funding up to $483 million to speed up development of the company's coronavirus vaccine. Moderna is currently leading the race to discover the most effective coronavirus vaccine, with its candidate already being tested in a clinical trial.
Moderna awarded up to $483M for coronavirus vaccine
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.